SPRINGFIELD, Ill. — H. D. Smith on Thursday announced the completion of the deal to attain majority interest in Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati.
“The completion of this acquisition affirms the service power of two highly specialized, focused organizations that help advance traditional and specialty brand pharmaceutical support offerings to manufacturing partners, specialty pharmacy customers, healthcare professionals and most importantly, patients with highly specialized healthcare needs,” stated Dale Smith, chairman and CEO H. D. Smith. “The benefit of Triplefin joining H. D. Smith Specialty Solutions is already seen across all channels of our business — we are now a stronger partner for brand and specialty manufacturers; a highly valuable service provider for institutions, acute care, physician offices, specialty and retail pharmacies; and a trusted supplier for patients expecting reliable access to prescription medicines.”
“The specialty health services model of today does more than just ensure that a product travels safely and securely from manufacturer to patient," said Joseph Conda, H. D. Smith Specialty Solutions president. "Today’s model must ensure that the needs of pharmacists, physicians, payers, group purchasing organizations and patients are met — from patient care information and education materials to clinical needs," he said. “With a larger and more diversified Specialty Solutions portfolio, we are now well equipped to provide varied services and support functions for all of the players involved in the care and treatment of patients requiring specialty pharmaceuticals.”
Under the original terms of the agreement, H. D. Smith achieved majority board representation in Triplefin immediately and recently secured majority stock ownership in the company. Financial terms of the acquisition remained confidential.